摘要
目的通过真实世界数据分析方法,评价芍苓方治疗寻常型银屑病的疗效和安全性。方法采用单中心、回顾性、单臂、真实世界临床研究的设计方法,收集广东省中医院病历系统数据库10年间有关芍苓方治疗寻常型银屑病患者的病例信息,患者予芍苓方内服,外用润肤剂作为基础治疗,疗程为2个月以上。以医师对病情整体评分(PGA)、体表受累面积(BSA)、银屑病皮损面积和严重程度指数(PASI)和瘙痒视觉模拟评估(VAS)作为疗效指标;以不良事件(AE)的发生情况作为安全性评价指标。结果最终纳入符合标准的银屑病患者共1374例,其中64.4%是男性,首诊PGA为(3.3±1.0)分,PASI为(6.3±5.6)分,BSA为(8.6±15.1)%,瘙痒VAS为(4.0±2.4)分。治疗后患者PGA、PASI、BSA、瘙痒VAS评分较治疗前明显改善,差异有统计学意义(P<0.05);患者血尿常规、肝肾功能、凝血、血脂方面的医学检查未见有临床意义的变化;不良事件分析中未发现与药物相关的严重不良事件。结论芍苓方主要用于治疗中度寻常型银屑病患者,可有效地改善和减轻患者的皮损症状、受累面积以及瘙痒症状,且临床用药安全性好。
Objective The aim of this study is to evaluate the effectiveness and safety of Shaoling formula for psoriasis vulgaris by analyzing real-world data in clinical practice.MethodsA single-center,retrospective,singlearm,real-world clinical study was conducted.From Guangdong Provincial Hospital of Chinese Medicine,electronic medical records of Shaoling formula for Psoriasis Vulgaris within 10 years were collected.All patients were given Shaoling formula for oral administration and moisturizers as an adjuvant role for over 2 months.The effectiveness and safety of the treatment were evaluated by physician’s global assessment(PGA),body surface area(BSA),psoriasis area and severity index(PASI),visual analogy score(VAS)for pruritus,and adverse events(AE).Results A total of 1374 patients were included in our study.The percentage of males was 64.4%.The value before initial treatment of PGA,PASI,BSA and VAS was(3.3±1.0),(6.3±5.6),(8.6±15.1)%,and(4.0±2.4)respectively.After treatment,all the evaluation indices were improved with statistical significance(P<0.05).And,there was no statistically significant difference of medical examinations before and after treatment,including blood and urine routine tests,liver and kidney function tests,the coagulation function test and the blood lipid examination.There was no severe adverse events relating to practical medicines.Conclusion Shaolingformula is effective for moderate psoriasis vulgaris,which can reduce skin lesion,surface area,and related symptoms(i.e.itch).And,the safety of the drugs has been proved.
作者
王俊月
何泽慧
邓浩
叶舒妍
闫玉红
姚丹霓
喻靖傑
谢秀丽
郭洁
卢传坚
WANG Junyue;HE Zehui;DENG Hao;YE Shuyan;YAN Yuhong;YAO Danni;YU Jingjie;XIE Xiuli;GUO Jie;LU Chuanjian(Psoriasis Clinical and Basic Research Team,Guangdong Provincial Hospital of Chinese Medicine,Guangzhou 510120 Guangdong,China;The Second Clinical Medical College,Guangzhou University of Chinese Medicine,Guangzhou 510000 Guangdong,China;Big Data of Chinese Medicine Research Team,Guangdong Provincial Hospital of Chinese Medicine,Guangzhou 510120 Guangdong,China;State Key Laboratory of Dampness Syndrome of Chinese Medicine,Guangzhou 510120 Guangdong,China;The Key Research Office of Standardization of Traditional Chinese Medicine,Guangdong Provincial Hospital of Chinese Medicine,Guangzhou 510120 Guangdong,China;Research Team of Academic Inheritance and Innovation About Famous Traditional Chinese Medicine Doctor,Guangdong Provincial Hospital of Chinese Medicine,Guangzhou 510120 Guangdong,China;Guangdong Provincial Hospital of Chinese Medicine,Guangdong Provincial Academy of Chinese Medical Sciences,Guangzhou 510120 Guangdong,China;Guangdong-Hong Kong-Macao Joint Laboratory of Chinese Medicine and Immune Diseases Research,Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome,Guangzhou 510120 Guangdong,China)
出处
《中药新药与临床药理》
CAS
CSCD
北大核心
2021年第5期739-743,共5页
Traditional Chinese Drug Research and Clinical Pharmacology
基金
2020广东省科技创新战略专项资金(粤港澳联合实验室)项目(2020B1212030006)
国家中医药管理局中医药传承与创新“百千万”人才工程(岐黄工程)岐黄学者支持经费(国中医药人教函[2018]288号)
国家中医药管理局国家中医临床研究基地项目(JDZX2015196)
省部共建中医湿证国家重点实验室专项(SZ2020ZZ15)
广东重点领域研发计划(2020B1111100005)
广东省中医院临床研究重点专项(YN2015MS07)。
关键词
芍苓方
润肤剂
真实世界研究
寻常型银屑病
疗效
安全性
Shaoling formula
moisturizers
a real-world study
psoriasis vulgaris
effectiveness
safety